Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
FRGT Freight Technologies	$1.56 -1.3%	$1.94	$1.45 ▼ $23.31	$3.61M	1.05	208,846 shs	35,765 shs
ISPC iSpecimen	$1.28 -28.9%	$1.13	$0.86 ▼ $8.30	$4.49M	1.65	471,358 shs	1.22 million shs
JADA Jade Art Group	$0.00	$0.00	$0.00 ▼ $0.01	$952K	1.11	3,392 shs	N/A
LPHM Lee Pharmaceuticals		$0.00	$0.01 ▼ $0.40	$3.48M	669.91	54,707 shs	24.51 million shs

7 AI Stocks to Invest in Today: Capitalizing on AI and Tech Trends in 2025

Discover the top 7 AI stocks to invest in right now. This exclusive report highlights the companies leading the AI revolution and shaping the future of technology in 2025.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
FRGT Freight Technologies	-1.27%	+4.00%	-15.22%	-68.80%	-91.24%
ISPC iSpecimen	-28.89%	-12.93%	+23.08%	+12.49%	+412.00%
JADA Jade Art Group	0.00%	0.00%	-5.91%	-26.07%	-58.60%
LPHM Lee Pharmaceuticals	0.00%	0.00%	0.00%	0.00%	-95.45%

Compare MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	Dividend Strength	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
FRGT Freight Technologies	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
ISPC iSpecimen	0.7781 of 5 stars	0.0	3.0	0.0	0.0	2.5	0.8	0.6
JADA Jade Art Group	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
LPHM Lee Pharmaceuticals	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Compare Analyst Forecasts

Company	Consensus Rating	Consensus Price Target	% Upside from Current Price
FRGT Freight Technologies	N/A	N/A	N/A
ISPC iSpecimen	N/A	N/A	N/A
JADA Jade Art Group	N/A	N/A	N/A
LPHM Lee Pharmaceuticals	N/A	N/A	N/A

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
FRGT Freight Technologies	$13.73M	0.26	N/A	N/A	($1.83) per share	-0.85
ISPC iSpecimen	$9.29M	0.34	N/A	N/A	$1.95 per share	0.66
JADA Jade Art Group	N/A	N/A	N/A	N/A	N/A	N/A
LPHM Lee Pharmaceuticals	N/A	N/A	N/A	N/A	N/A	N/A

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
FRGT Freight Technologies	-$5.60M	N/A	0.00	∞	N/A	N/A	N/A	N/A	8/15/2025 (Estimated)
ISPC iSpecimen	-$12.50M	-$12.89	N/A	∞	N/A	-139.63%	-285.20%	-114.37%	N/A
JADA Jade Art Group	N/A	N/A	0.00	∞	N/A	N/A	N/A	N/A	N/A
LPHM Lee Pharmaceuticals	N/A	N/A	0.00	N/A	N/A	N/A	N/A	N/A	N/A

Latest JADA, ISPC, FRGT, and LPHM Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue	Details
5/19/2025	Q1 2025	ISPC iSpecimen	N/A	-$0.71	N/A	-$0.71	N/A	$1.06 million
5/16/2025	Q1 2025	FRGT Freight Technologies	N/A	-$2.92	N/A	-$0.73	N/A	$4.10 million

Compare Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
FRGT Freight Technologies	N/A	N/A	N/A	N/A	N/A
ISPC iSpecimen	N/A	N/A	N/A	N/A	N/A
JADA Jade Art Group	N/A	N/A	N/A	N/A	N/A
LPHM Lee Pharmaceuticals	N/A	N/A	N/A	N/A	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
FRGT Freight Technologies	N/A	1.05	1.05
ISPC iSpecimen	N/A	0.31	0.31
JADA Jade Art Group	N/A	N/A	N/A
LPHM Lee Pharmaceuticals	N/A	N/A	N/A

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
FRGT Freight Technologies	6.24%
ISPC iSpecimen	13.62%
JADA Jade Art Group	N/A
LPHM Lee Pharmaceuticals	N/A

Insider Ownership

Company	Insider Ownership
FRGT Freight Technologies	9.00%
ISPC iSpecimen	12.20%
JADA Jade Art Group	N/A
LPHM Lee Pharmaceuticals	55.00%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
FRGT Freight Technologies	80	2.29 million	2.08 million	Not Optionable
ISPC iSpecimen	60	2.50 million	2.19 million	Not Optionable
JADA Jade Art Group	35	459.98 million	N/A	Not Optionable
LPHM Lee Pharmaceuticals	1	35.16 million	15.82 million	Not Optionable

JADA, ISPC, FRGT, and LPHM Headlines

Recent News About These Companies

Gan & Lee Pharmaceuticals Presented Multiple Results in Novel Diabetes Therapies at the American Diabetes Association's 85th Scientific Sessions

June 21, 2025 | prnewswire.com

Gan & Lee Pharmaceuticals Announced First Participant Dosed in the US Phase 2 Clinical Study of Bofanglutide (GZR18) Injection for Overweight or Obesity

March 10, 2025 | prnewswire.com

Gan & Lee Pharmaceuticals divulges new antibody-drug conjugates

December 25, 2024 | bioworld.comB

Gan & Lee Pharmaceuticals Announced Positive Phase 1 Results for Its Oral GLP-1 Receptor Agonist GZR18 Tablet in Healthy Participants, Demonstrating 4.16% Weight Reduction in Two Weeks

November 12, 2024 | prnewswire.com

ObesityWeek®? 2024 | Gan & Lee Pharmaceuticals Orally Presents Phase 2b Clinical Data for GZR18 Injection in Chinese Overweight and Obese Adults

November 11, 2024 | medindia.netM

Longboard Pharmaceuticals (LBPH) Receives a Hold from Truist Financial

November 11, 2024 | markets.businessinsider.com

ObesityWeek®️ 2024 | Gan & Lee Pharmaceuticals Orally Presents Phase 2b Clinical Data for GZR18 Injection in Chinese Overweight and Obese Adults

November 11, 2024 | prnewswire.com

Gan & Lee Pharmaceuticals' Three Innovative Drugs: GZR18 Injection, GZR4 Injection, and GZR101 Injection Achieve Primary Endpoints in Phase 2 Clinical Studies

October 15, 2024 | prnewswire.com

Assessing Longboard Pharmaceuticals’ Acquisition: Undervalued Potential Amidst Industry Interest

October 14, 2024 | markets.businessinsider.com

FTC Files Suit Against the Three Largest Pharmacy Benefit Managers

October 10, 2024 | jdsupra.com

Mat2A inhibitors reported in Gan & Lee Pharmaceuticals patent

September 27, 2024 | bioworld.comB

Gan & Lee Pharmaceuticals Presented Two Positive Clinical Results of Once-weekly Insulin GZR4 at the 60th Annual Meeting of the European Association for the Study of Diabetes (EASD 2024)

September 14, 2024 | prnewswire.com

Austin Lee Resourcing

August 21, 2024 | pmlive.comP

Lee Health Embraces AI to Support Patient Care, Improve Health Outcomes, and Increase Efficiency

August 10, 2024 | smdailyjournal.comS

Franklin Regional graduate Spencer Lee soars to semi-finals in Paris Olympics 57kg FreeStyle

August 9, 2024 | msn.com

Gymnastics-Lee credits doctors and team for lifting her to Paris Olympic glory

August 6, 2024 | reuters.com

Gymnastics-Lee overcomes illness, criticism to return to Olympic podium

August 1, 2024 | reuters.com

Gan & Lee Pharmaceuticals' Bi-weekly (twice a month) GLP-1 Receptor Agonist GZR18 Injection Achieved 17.29% Weight Loss at 30 Weeks in a Phase IIb Clinical Trial

July 22, 2024 | prnewswire.com

Gan & Lee Pharmaceuticals Announces Significant Progress on New Diabetes and Obesity Treatments at the American Diabetes Association's 84th Scientific Sessions

June 22, 2024 | prnewswire.com

Gan & Lee Pharmaceuticals to Present Groundbreaking Data on Three Innovative Products at the American Diabetes Association's 84th Scientific Sessions

June 17, 2024 | prnewswire.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

JADA, ISPC, FRGT, and LPHM Company Descriptions

Freight Technologies NASDAQ:FRGT

$1.56 -0.02 (-1.27%)

Closing price 08/8/2025 03:59 PM Eastern

Extended Trading

$1.58 +0.02 (+1.60%)

As of 08/8/2025 07:40 PM Eastern

Freight Technologies, Inc., through its subsidiary, operates a transportation logistics technology platform for cross-border shipping in the United States and Mexico. Its Fr8App technology platform offers an online portal and a mobile application that provide third-party logistics services to companies in the freight transportation market; a transport management solution for customers to manage their own fleet; and freight brokerage support and customer services based on the platform. The company was incorporated in 2015 and is headquartered in The Woodlands, Texas.

iSpecimen NASDAQ:ISPC

$1.28 -0.52 (-28.89%)

Closing price 08/8/2025 04:00 PM Eastern

Extended Trading

$1.16 -0.12 (-9.30%)

As of 08/8/2025 07:59 PM Eastern

iSpecimen Inc. provides technology that connects life science researchers who need human biofluids, tissues, and living cells for their research with biospecimens available in healthcare provider organizations worldwide. Its cloud-based technology enables scientists to search for specimens and patients across a network of hospitals, clinics, private practice groups, laboratories, blood centers, biobanks, clinical research sites, and cadaveric donation centers. The company develops and operates iSpecimen Marketplace, a proprietary online marketplace platform that connects medical researchers who need access to subjects, samples, and data with hospitals, laboratories, and other organizations who have access to them. It serves biopharmaceutical companies, in vitro diagnostic companies, and government/academic institutions. iSpecimen Inc. was incorporated in 2009 and is headquartered in Lexington, Massachusetts.

Jade Art Group OTCMKTS:JADA

$0.0021 0.00 (0.00%)

As of 08/8/2025

Jade Art Group Inc., through its subsidiary, JiangXi SheTai Jade Industrial Company Limited, engages in the sale and distribution of raw jade in China. It also involves in jade processing, carving, and polishing activities. The company's products are used as decorative construction material in commercial and residential markets, and high-end jewelry. Jade Art Group Inc. is based in Yingtan, China.

Lee Pharmaceuticals OTCMKTS:LPHM

Lee Pharmaceuticals, Inc., through its subsidiary, RONN Motor Group, Inc., focuses on the design and development, manufacture, marketing, and sale of all-electric, hydrogen-fuel cell, and zero-emission new energy vehicles (NEVs) in the United States, China, and internationally. It intends to offer hydrogen fuel cell NEVs, including sports cars, sedans, SUVs, trucks, and buses. The company was founded in 2013 and is based in Scottsdale, Arizona.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time